First Glance with Jody Vance Podcast header image 1

First Glance with Jody Vance Podcast

26
Jul 2021

Game On Entertainment Technologies (GET.C) CEO Matt Bailey on driving content engagement (Ep 62) First Glance with Jody Vance

Matt Bailey, Game On Technologies (GET.C), talks about the potential of engaging content consumers through gamifying content with social interaction as well as prizes and polls, giving users an enhanced experience while developing a stronger relationship between content providers such as sports teams, networks and entertainment events, and their audience. Listen in!

9
Jul 2021

Bioasis Technologies (TSX.V: BTI) (OTCQB: BIOAF) CEO, Deborah Rathjen on the blood-brain barrier (Ep 44)

Deborah Rathjen, CEO of Bioasis Technologies (BTI.V) talks about the company's ground-breaking xB3 platform which allows therapeutic drugs to pass through the seemingly impenetrable blood-brain barrier, providing an effective treatment methodology for such neurological disorders as Alzheimer's disease, Lewy Body Dementia and Parkinson's. In short, Bioasis' final frontier solution could very well revolutionize medical science, potentially helping to heal the one billion people suffering from neurological disorders worldwide. Tune in!

5
Jul 2021

Biovaxys (BIOV.C) Founder & CEO James Passin talks about their tech, Covid & cancer treatment (Ep56)

In this show, Vancouver-based sportscast icon, Rob Fai, fills in for Jody Vance to talk to Biovaxys Founder and CEO, James Passin. They talk about Biovaxys' journey before going public and what they have planned ahead regarding solutions to Covid and cancer treatment.

5
Jul 2021

Diagnos (ADK.V) President & CEO Andre Larente with updates on IRIS The Visual Group deal (Ep 55)

Vancouver broadcasting icon, Jody Vance, speaks with Andre Larente, president and CEO of DIAGNOS (ADK.V) to get an update on the company's recent agreement with IRIS the Vision Group and it's importance to optometrists and Canadians. Tune in!

For more details: https://equity.guru/2021/06/10/diagnos-adk-v-latest-agreement-with-iris-the-vision-group-aims-to-help-canadians-see-better/

5
Jul 2021

Mountain Valley MD (MVMD.C) CEO, Dennis Hancock talks about Ivermectin, Covid & cancer (Ep 54)

Much-loved Vancouver broadcasting icon, Jody Vance, speaks with Dennis Hancock, president and CEO of Mountain Valley MD (MVMD.C) to get an update on the company's rocketing market cap, plans for a new FDA pathway for its Ivermectin solution for Covid and what shareholders can expect to see over the next 12 months. Tune in!

5
Jul 2021

Nouveau Monde Graphite (NOU.V) CEO, Eric Desaulniers & their all-electric graphite mine (Ep 53)

Vancouver broadcasting icon, Jody Vance, talks to Nouveau Monde Graphite CEO, Eric Desaulniers about the transition to a green future through sustainable Zero-Carbon SolutionsTM and the mission to produce the greenest advanced graphite materials with a carbon-neutral footprint for a sustainable world. The Company is developing advanced carbon-neutral graphite-based material solutions for the growing lithium-ion and fuel cell markets. Listen in!

5
Jul 2021

DMG Blockchain Solutions (DMGI.V) CEO, Sheldon Bennett on their model, solutions & Bitcoin (Ep 52)

Much-loved Vancouver broadcasting icon, Jody Vance, speaks with DMG Blockchain Solutions CEO & Director, Sheldon Bennett. Bennett has over 20 years of management experience leading international companies, including PwC, Ernst & Young, Baker & McKenzie, and Cisco Systems before founding DMG Blockchain Solutions. In this episode, they go over DMG Blockchain Solutions' vision and role in the future of cryptocurrency and its mining industry.

4
May 2021

Core One Labs (COOL) CEO Joel Shacker gives an update on their biosynthetic psilocybin formulation ( EP 51) FG/JV

Much-loved Vancouver radio personality Jody Vance connects with Joel Shacker, CEO of Core One Labs, to discuss biosynthetic psilocybin, their novel delivery system, and plans for the future. Subscribe and Tune in! 

22
Apr 2021

Mountain Valley MD (MVMD) CEO Dennis Hancock give an update on the progress of their ivermectin trials (EP 50) FG/JV

Much-loved Vancouver broadcasting icon, Jody Vance, speaks with Dennis Hancock, president and CEO of Mountain Valley MD (MVMD.C) to get an update on the company's rocketing market cap, plans for a new FDA pathway for its Ivermectin solution for Covid, and what shareholders can expect to see over the next 12 months. Tune in and subscribe! 

22
Apr 2021

Valeo Pharma (VPH) President and CEO Steve Saviuk updates us on their Novartis Agreement (EP 48) FG/JV

Prominent Vancouver radio personality Jody Vance speaks with Valeo Pharma President and CEO Steve Saviuk about their Novartis agreement and their latest round of financing. Subscribe and Tune in! 

Podbean App

Play this podcast on Podbean App